Companion Diagnostics: Strategic Intelligence
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Companion diagnostics (CDx) are medical devices, most commonly an in vitro diagnostic (IVD) that provides information necessary for the safe and effective use of a corresponding drug or biological product. CDx support the expansion of personalized medicine by assessing predictive biomarkers, such as genetic variation or protein expression, in individual patients to determine the most effective use of an associated therapy.
Scope
Oncology is still the most common use for companion diagnostics, as they play a crucial role in the development of targeted therapies
Companion diagnostics can be used to identify patients who are likely to benefit from a particular therapy
There is potential for companion diagnostics to be applied in other therapy areas, such as rare diseases, neurological disorders and cardiovascular diseases.
Reasons to Buy
Understand how companion diagnostics are evolving, the current uses and future potential.
Understand the key players, the challengers, and product offerings.
Understand key applications of companion diagnostics.
Roche
Sysmex
bioMérieux
Asuragen
Thermo Fisher Scientific
NimaGen
Illumina
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745